Muccosinal (Acetylcysteine)

Acetylcysteine cleaves disulfide bonds in mucoprotein polymers, reducing mucus viscosity and elasticity. The thinner mucus is more easily moved by ciliary action and coughing, enhancing clearance from the airways and helping patients breathe more comfortably.

The dosage of Muccosinal is determined by the prescribing healthcare professional based on the patient’s condition, age, weight and renal function. The prescriber will set the appropriate strength, frequency and duration of therapy.

Safety data for acetylcysteine in pregnancy and lactation are limited. It should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under the guidance of a qualified clinician.

To place an order, submit an enquiry on the Muccosinal product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Acetylcysteine differs from other mucolytics such as carbocisteine or bromhexine by directly breaking disulfide bonds in mucus, leading to a rapid reduction in viscosity. While carbocisteine modulates mucus production and bromhexine enhances ciliary activity, acetylcysteine’s mechanism provides a more immediate thinning effect, which can be advantageous in acute exacerbations.

Muccosinal should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the container tightly closed and out of reach of children.

Muccosinal is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the specific instructions provided by their prescriber to ensure optimal absorption and effect.

The most serious adverse reactions, although rare, include anaphylactic shock, severe skin reactions such as Stevens‑Johnson syndrome, and hepatic dysfunction manifested by abnormal liver enzyme levels. Patients should seek immediate medical attention if they experience signs of an allergic reaction or unexplained liver issues.

Muccosinal is contraindicated in individuals with a known hypersensitivity to acetylcysteine or any of its excipients. Caution is also advised for patients with severe renal impairment, and it should be avoided in those who have experienced severe allergic reactions to mucolytic agents.